Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Drug Formulation Market Expected to Be in 2029?

The pharmaceutical formulation market has been witnessing robust growth in the past few years. The market size is projected to expand from $1908.89 billion in 2024 to $2045.31 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors such as innovation in biopharmaceuticals, drug development focused on patients, personalized healthcare, regulatory encouragement for rare disease drugs, and enhanced R&D spending have contributed to the growth in the historical period.

The market for drug formulation is set to experience robust expansion in the coming years, with projections indicating a growth to $2894.29 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.1%. This anticipated growth over the forecast period is due largely to developments in 3d printing, a heightened focus on pediatric formulations, the adoption of biological drug delivery systems, the incorporation of green chemistry in formulation alongside the integration of artificial intelligence (ai). Noteworthy trends within the forecast period comprise a dominance of biopharmaceuticals and biologics, the emergence of advanced drug delivery systems, the rising traction of personalized medicine and individualized formulations, the introduction of nanotechnology, along with lifecycle management and reformulation strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

What Are The Contributors To Demand In The Drug Formulation Market?

The anticipated growth of the drug formulation market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases are typically defined as conditions that persist for more than a year and necessitate regular medical care, interfere with daily activities, or both. Drug formulation has the potential to alleviate chronic illnesses by using various drug delivery techniques to boost therapeutic effectiveness while reducing adverse effects through influencing the absorption, distribution, metabolism, and excretion of medication. For example, a September 2022 report by the National Institutes of Health (NIH), a US biomedical research institution, forecasted a 99.5% increase in the population of Americans aged 50 and over with at least one chronic disease, from 71.52 million in 2020 to 142.66 million in 2050. Furthermore, the number of people with multiple chronic conditions is projected to grow by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. As a result, the escalating incidences of chronic diseases are propelling the expansion of the drug formulation market.

What Segmentation Categories Are Included In The Drug Formulation Market Analysis?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

What Upcoming Trends Are Expected To Impact The Drug Formulation Market Globally?

One of the emerging trends in the drug formulation sector is technological innovation. Key market participants are focusing on the introduction of new and enhanced technologies to consolidate their market stance. An example of this is the launching of the Merck Digital Sciences Studio (MDSS) by Merck & Co., Inc., a pharmaceutical company from the United States, in June 2022. This initiative zooms in on fostering the development of fresh technologies for drug research, courtesy of Azure Cloud’s potent computing and Merck’s discovery and clinical professionals. The initiative, which is a joint effort between Merck and the New Jersey Innovation Institute (NJII), an entity owned by the New Jersey Institute of Technology in the US, has attracted investment from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures. Microsoft will be offering technological backing for start-up organizations.

Who Are The Top-Ranked Companies In The Drug Formulation Market Today?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

How Is Drug Formulation Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model